CMR phenotyping in sarcoidosis: a leap forward, but is simplicity the ultimate sophistication?
- 19 December 2025
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (8) , 988-989
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Extent and Features of Late Gadolinium Enhancement Stratify Arrhythmic Risk in Patients With Biopsy-Proven SarcoidosisJACC: Cardiovascular Imaging, 2025
- Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis: a comparison of cardiovascular magnetic resonance phenotyping vs. societal recommendations for implantable cardioverter-defibrillator placementEuropean Heart Journal, 2025
- Magnetic Resonance Imaging in the Assessment of the Risk of Sudden Death in Cardiac Sarcoidosis: What Is Extensive or Significant Late Gadolinium Enhancement?Circulation: Arrhythmia and Electrophysiology, 2025
- Specific locations of myocardial inflammation and fibrosis are associated with higher risk of events in cardiac sarcoidosisHeart Rhythm, 2024
- Risk Stratification in Cardiac Sarcoidosis With Cardiac Positron Emission TomographyJACC: Cardiovascular Imaging, 2024
- Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac SarcoidosisCirculation: Arrhythmia and Electrophysiology, 2019
- Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac SarcoidosisJACC: Cardiovascular Imaging, 2018